Lipodystrophy
In 1885, Weir-Miechell first reported partial lipodystrophy. Later, it was reported that patients had lipodystrophy in the neck, arms, chest and abdomen, accompanied by increased fat deposition in the hips and legs. In 1946, Lawrence reported complete lipodystrophy. The patients' fat malnutrition was systemic, complete or patchy, and the lack of fat was often accompanied by a series of metabolic disorders.
-
Site of disease:
Whole body kidney -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Azotemia Simple upper body emaciation type Dimples on both cheeks and temporal regions Muscle hypertrophy Proteinuria -
Concurrent disease:
Related Drugs
Enteral Nutrition Emulsion (TP)
Indication: This product is suitable for patients with malnutrition or dietary disorders of gastrointestinal function, including patients after trauma or craniofacial and cervical surgery; patients with difficulty chewing and swallowing; patients with unclear consciousness or receiving mechanical ventilation; patients who need nutritional supplements after surgery; patients with anorexia nervosa, etc. This product does not contain dietary fiber and can be used for patients with severe gastrointestinal stenosis; patients with intestinal fistula; and preoperative or pre-diagnosis intestinal preparation.
Related Ingredients
-
Α-protein list
146317-23-9 -
fatty acid list
9150-89-4